143 related articles for article (PubMed ID: 8294310)
21. Platelet coagulation-protein interactions.
Walsh PN
Semin Thromb Hemost; 2004 Aug; 30(4):461-71. PubMed ID: 15354267
[TBL] [Abstract][Full Text] [Related]
22. Coagulation 2006: a modern view of hemostasis.
Hoffman M; Monroe DM
Hematol Oncol Clin North Am; 2007 Feb; 21(1):1-11. PubMed ID: 17258114
[TBL] [Abstract][Full Text] [Related]
23. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
Despotis GJ; Joist JH
J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
[TBL] [Abstract][Full Text] [Related]
24. Theories of blood coagulation.
Riddel JP; Aouizerat BE; Miaskowski C; Lillicrap DP
J Pediatr Oncol Nurs; 2007; 24(3):123-31. PubMed ID: 17475978
[TBL] [Abstract][Full Text] [Related]
25. Human thrombi contain an abundance of active thrombin.
Mutch NJ; Robbie LA; Booth NA
Thromb Haemost; 2001 Oct; 86(4):1028-34. PubMed ID: 11686320
[TBL] [Abstract][Full Text] [Related]
26. Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition.
Momi S; Nasimi M; Colucci M; Nenci GG; Gresele P
Haematologica; 2001 Mar; 86(3):297-302. PubMed ID: 11255277
[TBL] [Abstract][Full Text] [Related]
27. Bothrojaracin: a potent two-site-directed thrombin inhibitor.
Arocas V; Zingali RB; Guillin MC; Bon C; Jandrot-Perrus M
Biochemistry; 1996 Jul; 35(28):9083-9. PubMed ID: 8703912
[TBL] [Abstract][Full Text] [Related]
28. Progress in the design of low molecular weight thrombin inhibitors.
Srivastava S; Goswami LN; Dikshit DK
Med Res Rev; 2005 Jan; 25(1):66-92. PubMed ID: 15389730
[TBL] [Abstract][Full Text] [Related]
29. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M
J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701
[TBL] [Abstract][Full Text] [Related]
30. Modes and consequences of thrombin's interaction with fibrin.
Fredenburgh JC; Stafford AR; Pospisil CH; Weitz JI
Biophys Chem; 2004 Dec; 112(2-3):277-84. PubMed ID: 15572259
[TBL] [Abstract][Full Text] [Related]
31. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
von dem Borne PA; Cox LM; Bouma BN
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
[TBL] [Abstract][Full Text] [Related]
32. Protocol and preliminary results of a clinical study for comparison of solvent/detergent-inactivated plasma VIP versus FFP with special consideration of the balance of hemostasis.
Beck KH; Mortelmans Y; Kretschmer V
Beitr Infusionsther Transfusionsmed; 1994; 32():440-4. PubMed ID: 9422123
[TBL] [Abstract][Full Text] [Related]
33. A personal perspective on hemostasis and thrombosis (1937-1981).
Seegers WH
Semin Thromb Hemost; 1981 Dec; 7(3-4):177-307. PubMed ID: 7034202
[No Abstract] [Full Text] [Related]
34. Thrombin activatable fibrinolysis inhibitor (TAFI) and markers of endothelial cell injury in dialyzed patients with diabetic nephropathy.
Małyszko J; Małyszko JS; Hryszko T; Myśliwiec M
Thromb Haemost; 2004 Mar; 91(3):480-6. PubMed ID: 14983223
[TBL] [Abstract][Full Text] [Related]
35. [The role of lipids and lipoproteins in hemostatic processes].
Worowski K; Farbiszewski R
Postepy Biochem; 1970; 16(1):51-66. PubMed ID: 4907179
[No Abstract] [Full Text] [Related]
36. Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis.
Vandendries ER; Hamilton JR; Coughlin SR; Furie B; Furie BC
Proc Natl Acad Sci U S A; 2007 Jan; 104(1):288-92. PubMed ID: 17190826
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic effect of a low molecular weight dermatan sulphate (Desmin 370) in rat venous thrombosis--evidence for an anticoagulant-independent mechanism.
Barbanti M; Calanni F; Milani MR; Marchi E; Semeraro N; Colucci M
Thromb Haemost; 1993 Feb; 69(2):147-51. PubMed ID: 8456427
[TBL] [Abstract][Full Text] [Related]
38. Changes in molecular markers of hemostatic and fibrinolytic activation under various sampling conditions using vacuum tube samples from healthy volunteers.
Omote M; Asakura H; Takamichi S; Shibayama M; Yoshida T; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Nakao S; Wada T
Thromb Res; 2008; 123(2):390-5. PubMed ID: 18579183
[TBL] [Abstract][Full Text] [Related]
39. A role for thrombin receptor signaling in endothelial cells during embryonic development.
Griffin CT; Srinivasan Y; Zheng YW; Huang W; Coughlin SR
Science; 2001 Aug; 293(5535):1666-70. PubMed ID: 11533492
[TBL] [Abstract][Full Text] [Related]
40. [The effect of the coagulation and fibrinolysis system on wound healing and thrombus organization].
Bruhn HD; Christophers E; Pohl J
Verh Dtsch Ges Inn Med; 1978; (84):1345-8. PubMed ID: 741962
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
